Dara Biosciences Inc (DARA) financial statements (2023 and earlier)

Company profile

Business Address 8601 SIX FORKS ROAD SUITE 160
RALEIGH, NC 27615
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12,0273,4266,593
Cash and cash equivalents12,0273,4266,496
Short-term investments  96
Receivables1,355174173
Inventory, net of allowances, customer advances and progress billings265104125
Inventory265104125
Prepaid expense and other current assets153
Other undisclosed current assets127185 
Total current assets:13,7743,8897,045
Noncurrent Assets
Property, plant and equipment364150
Intangible assets, net (including goodwill)3,9304,0464,530
Goodwill821821821
Intangible assets, net (excluding goodwill)3,1093,2253,709
Restricted cash and investments131313
Prepaid expense and other noncurrent assets54
Total noncurrent assets:3,9794,0994,647
TOTAL ASSETS:17,7527,98811,692
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,3061,5291,882
Accounts payable4836201,383
Accrued liabilities1,170785327
Employee-related liabilities653124172
Debt747
Other undisclosed current liabilities1,432142150
Total current liabilities:3,7451,6752,039
Noncurrent Liabilities
Long-term debt and lease obligation221620
Capital lease obligations221620
Liabilities, other than long-term debt697341
Deferred revenue and credits697341
Other undisclosed noncurrent liabilities 662599
Total noncurrent liabilities:91751660
Total liabilities:3,8362,4262,699
Stockholders' equity
Stockholders' equity attributable to parent, including:13,9166,6099,638
Preferred stock  0
Common stock198310189
Additional paid in capital79,71263,29256,430
Accumulated other comprehensive income  45
Accumulated deficit(65,994)(56,993)(47,028)
Other undisclosed stockholders' equity attributable to parent000
Stockholders' equity attributable to noncontrolling interest (1,047)(645)
Total stockholders' equity:13,9165,5628,993
TOTAL LIABILITIES AND EQUITY:17,7527,98811,692

Income statement (P&L) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Revenues1,88741954
Revenue, net  54
Cost of revenue
(Cost of Goods and Services Sold)
(708)(219)(24)
Gross profit:1,17820030
Operating expenses(11,287)(10,690)(9,667)
Other undisclosed operating income708  
Operating loss:(9,400)(10,489)(9,637)
Nonoperating income163150597
Other nonoperating income228145 
Interest and debt expense (67)(12)
Other undisclosed income from continuing operations before equity method investments, income taxes  12
Loss from continuing operations before equity method investments, income taxes:(9,237)(10,406)(9,040)
Other undisclosed income from continuing operations before income taxes 67 
Loss from continuing operations before income taxes:(9,237)(10,339)(9,040)
Income tax expense (benefit) (29)1,300
Net loss:(9,237)(10,368)(7,740)
Net income attributable to noncontrolling interest236403429
Net loss available to common stockholders, diluted:(9,001)(9,965)(7,311)

Comprehensive Income ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Net loss:(9,237)(10,368)(7,740)
Other comprehensive income  45
Other undisclosed comprehensive income  8,124
Comprehensive income (loss):(9,237)(10,368)429
Comprehensive income (loss), net of tax, attributable to noncontrolling interest236403(429)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 9,920(7,695)
Comprehensive loss, net of tax, attributable to parent:(9,001)(45)(7,695)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: